SMALL-MOLECULE INHIBITORS bULKing up mTOR inhibition

被引：1
|
作者：
Goodwin, Jonathan M. [1 ]
Murphy, Leon O. [1 ]
机构：
[1] Novartis Inst BioMed Res, Cambridge, MA 02139 USA
来源：
NATURE CHEMICAL BIOLOGY | 2015年 / 11卷 / 10期
关键词：
DIRECT PHOSPHORYLATION; IN-VIVO; AUTOPHAGY; KINASE; TARGET; VPS34; ULK1;
D O I：
10.1038/nchembio.1909
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A new small-molecule inhibitor of the autophagy-initiating kinase ULK1 serves to block a critical survival mechanism activated upon inhibition of mTORC1, potentially enhancing treatment efficacy for mTOR inhibitors currently in clinical trials for cancer treatment.
引用
收藏
页码：758 / 760
页数：4
相关论文
共 50 条
  • [31] Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a
    Zhong, Yueling
    Xu, Hong
    Zhong, Yi
    Zhang, Xuemiao
    Zeng, Ting
    Li, Limei
    Xu, Gaojie
    Li, Minhui
    Liu, Jin
    Yang, Tai
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 19 (01):
  • [32] Design, synthesis, and evaluation of fluoroquinolone derivatives as microRNA-21 small-molecule inhibitors
    Hei, Yuan -Yuan
    Wang, Si
    Xi, Xiao-Xiao
    Wang, Hai-Peng
    Guo, Yuanxu
    Xin, Minhang
    Jiang, Congshan
    Lu, Shemin
    Zhang, San-Qi
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2022, 12 (04) : 653 - 663
  • [33] Recent Developments of Small Molecule PI3K/mTOR Dual Inhibitors
    Liu, Yan-Na
    Wan, Ren-Zhong
    Liu, Zhao-Peng
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (14) : 2047 - 2059
  • [34] Selective small-molecule EPAC activators
    Luchowska-Stanska, Urszula
    Morgan, David
    Yarwood, Stephen J.
    Barker, Graeme
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2019, 47 : 1415 - 1427
  • [35] Mechanism of Inhibition of Cholesteryl Ester Transfer Protein by Small Molecule Inhibitors
    Chirasani, Venkat R.
    Sankar, Revathi
    Senapati, Sanjib
    JOURNAL OF PHYSICAL CHEMISTRY B, 2016, 120 (33) : 8254 - 8263
  • [36] Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
    Hu, Jiarui
    Zhang, Dan
    Tian, Keyue
    Ren, Changyu
    Li, Heng
    Lin, Congcong
    Huang, Xiaoli
    Liu, Jie
    Mao, Wuyu
    Zhang, Jifa
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 256
  • [37] Small-molecule inhibitors of histone deacetylase improve CRISPR-based adenine base editing
    Shin, Ha Rim
    See, Ji-Eun
    Kweon, Jiyeon
    Kim, Heon Seok
    Sung, Gi-Jun
    Park, Sojung
    Jang, An-Hee
    Jang, Gayoung
    Choi, Kyung-Chul
    Kim, Inki
    Kim, Jin-Soo
    Kim, Yongsub
    NUCLEIC ACIDS RESEARCH, 2021, 49 (04) : 2390 - 2399
  • [38] Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma
    Hirano, Mitsuhito
    Imai, Yoichi
    Kaito, Yuta
    Murayama, Takahiko
    Sato, Kota
    Ishida, Tadao
    Yamamoto, Junichi
    Ito, Takumi
    Futami, Muneyoshi
    Ri, Masaki
    Yasui, Hiroshi
    Denda, Tamami
    Tanaka, Yukihisa
    Ota, Yasunori
    Nojima, Masanori
    Kamikubo, Yasuhiko
    Gotoh, Noriko
    Iida, Shinsuke
    Handa, Hiroshi
    Tojo, Arinobu
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [39] Tampering with Cell Division by Using Small-Molecule Inhibitors of CDK-CKS Protein Interactions
    Hamdi, Amel
    Lesnard, Aurelien
    Suzanne, Peggy
    Robert, Thomas
    Miteva, Maria A.
    Pellerano, Morgan
    Didier, Bruno
    Ficko-Blean, Elizabeth
    Lobstein, Annelise
    Hibert, Marcel
    Rault, Sylvain
    Morris, May C.
    Colas, Pierre
    CHEMBIOCHEM, 2015, 16 (03) : 432 - 439
  • [40] Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
    Erdonmez, Burak
    Altintop, Mehlika Dilek
    Ciftci, Gulsen Akalin
    Ozdemir, Ahmet
    Ece, Abdulilah
    ACS OMEGA, 2023, 8 (22): : 20056 - 20065
12345